Schlagwörter
BEVACIZUMAB
6
CHEMOTHERAPY
6
1ST-LINE TREATMENT
2
BRAF MUTATION
2
CANCER PATIENTS
2
COLON-CANCER
2
CONTROLLED-TRIAL
2
Colorectal cancer
2
EARLY RECURRENCE
2
HEPATECTOMY
2
HEPATIC RESECTION
2
III TRIAL
2
Liver metastases
2
Local treatment
2
MUTATION STATUS
2
OUTCOMES
2
OXALIPLATIN
2
Oncology
2
Outcome
2
PLUS
2
RISK-FACTORS
2
Recurrence
2
Resectability
2
STRATEGIES
2
SURGERY
2
SURVIVAL
2
Surgery
2
Treatment strategies
2
UPDATED ANALYSIS
2
Unresectable colorectal liver metastases
2